European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary team.

IF 2 4区医学 Q3 ONCOLOGY Tumori Pub Date : 2024-12-06 DOI:10.1177/03008916241303022

Cristiana Sessa, Luzia Travado, Gabriele Calaminus, Teresa Margarida Cunha, Roberto C Delgado Bolton, Willemien van Driel, Andreia Fernandes, Margaret Hutka, Birthe Lemley, Natalia Luczak, Rui Medeiros, Simon Oberst, Nelleke Ottevanger, Andrea Papadia, Philippe Pereira, Manuel Rodrigues, Simona Stolnicu, Katrien Vandecasteele, Alberto Costa, Philip Poortmans, Fedro Peccatori

{"title":"European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary team.","authors":"Cristiana Sessa, Luzia Travado, Gabriele Calaminus, Teresa Margarida Cunha, Roberto C Delgado Bolton, Willemien van Driel, Andreia Fernandes, Margaret Hutka, Birthe Lemley, Natalia Luczak, Rui Medeiros, Simon Oberst, Nelleke Ottevanger, Andrea Papadia, Philippe Pereira, Manuel Rodrigues, Simona Stolnicu, Katrien Vandecasteele, Alberto Costa, Philip Poortmans, Fedro Peccatori","doi":"10.1177/03008916241303022","DOIUrl":null,"url":null,"abstract":"<p><p>European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) are written by experts representing all disciplines involved in cancer care in Europe. They give patients, health professionals, managers and policymakers a guide to essential care. Here, the essential requirements to treat ovarian cancer patients are described. Ovarian cancer patients continue to have low cure rates with wide variation in treatment and care in Europe and beyond. They require complex treatment that should be carried out in specialised ovarian/gynaecological cancer centres by professionals with the appropriate expertise interacting in a multidisciplinary team. Such centralisation is still not well established in many European countries. A patient-centred pathway from diagnosis through treatment to survivorship, managed in dedicated centres, is key to achieving optimal care and a successful clinical outcome.</p>","PeriodicalId":23349,"journal":{"name":"Tumori","volume":" ","pages":"3008916241303022"},"PeriodicalIF":2.0000,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumori","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03008916241303022","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) are written by experts representing all disciplines involved in cancer care in Europe. They give patients, health professionals, managers and policymakers a guide to essential care. Here, the essential requirements to treat ovarian cancer patients are described. Ovarian cancer patients continue to have low cure rates with wide variation in treatment and care in Europe and beyond. They require complex treatment that should be carried out in specialised ovarian/gynaecological cancer centres by professionals with the appropriate expertise interacting in a multidisciplinary team. Such centralisation is still not well established in many European countries. A patient-centred pathway from diagnosis through treatment to survivorship, managed in dedicated centres, is key to achieving optimal care and a successful clinical outcome.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Tumori 医学-肿瘤学

CiteScore

3.50

自引率

0.00%

发文量

审稿时长

6 months

期刊介绍： Tumori Journal covers all aspects of cancer science and clinical practice with a strong focus on prevention, translational medicine and clinically relevant reports. We invite the publication of randomized trials and reports on large, consecutive patient series that investigate the real impact of new techniques, drugs and devices inday-to-day clinical practice.